Turkish version of the Pain and Smoking Inventory
Official title: Turkish Cultural Adaptation and Psychometric Properties of the Pain and Smoking Inventory in Individuals With Chronic Pain
Run by Hacettepe University · NCT07673926 · Data updated 2026-11-12
Researchers are translating the Pain and Smoking Inventory into Turkish and checking if it reliably measures pain and smoking behavior among Turkish adults who smoke and have chronic pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 2 sites (Bingoel and 1 other locations) |
| Status | Recruiting |
| Started | September 15, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07673926 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with chronic pain for at least 3 months who smoke at least 5 cigarettes per day and can read and write Turkish.
✕Probably not a fit
Individuals who do not smoke or do not have chronic pain, or those unable to complete Turkish-language questionnaires, may not benefit from this adaptation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cross-cultural adaptation study conducted in two Turkish sites that translates the Pain and Smoking Inventory into Turkish and then assesses its psychometric properties. The process follows ISPOR guidelines, including forward and backward translations, expert review, and a pilot test with 10 participants. The study enrolls adults with chronic pain who smoke at least five cigarettes daily and can read Turkish, using paper forms and an online survey for data collection. The primary aim is to produce a Turkish version (PSI-TR) that is reliable and valid for this population.
Why it matters
Potential benefit: If successful, the PSI-TR could provide a valid tool for clinicians and researchers to assess the interplay between pain and smoking in Turkish-speaking patients.
How similar studies have gone: Previous cross-cultural adaptations of patient-reported measures have demonstrated good reliability and validity when following ISPOR guidelines; this study aligns with those established methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years and older. * Having a diagnosis of chronic pain that has persisted for at least 3 months. * Smoking at least 5 cigarettes per day (within the last 30 days). * Being able to read and write in Turkish. * Volunteering to participate in the study and signing the written informed consent form. Exclusion Criteria: * Having a diagnosis of active psychosis or severe depression. * Having a diagnosis of cognitive impairment or intellectual disability. * Having severe alcohol dependence or substance use disorder. * Having reading and writing difficulties to a degree that prevents completing the questionnaire independently. * Being in the pregnancy or breastfeeding period. * Using nicotine replacement therapy or smoking cessation medication within the last 1 month.
Where it's running
-
Bingol University Faculty of Physical Therapy and Rehabilitation
Bingoel, Turkey (Türkiye) Recruiting -
Bingöl State Hospital
Bingoel, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Aybüke Fanuscu
- Email: afanuscu@bingol.edu.tr
- Phone: +904262160012-5548
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.